Author: Taro White - Page 3

History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
Generic drugs now make up over 90% of U.S. prescriptions, saving billions annually. This is their story - from dangerous 19th-century medicines to the Hatch-Waxman Act and modern supply chain challenges.
Read More
Medication Safety Statistics: What Patients Need to Know to Avoid Harm
Medication Safety Statistics: What Patients Need to Know to Avoid Harm
Medication errors harm over 1.5 million people yearly. Learn the most dangerous drugs, why mistakes happen, and how to protect yourself from preventable harm-backed by global statistics and real-world data.
Read More
FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained
FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained
The FDA Office of Generic Drugs ensures affordable, high-quality generic medications reach patients by reviewing applications, enforcing bioequivalence standards, and managing patent exclusivity under GDUFA and the Hatch-Waxman Act.
Read More
Clindamycin and C. difficile Risk: When to Seek Care
Clindamycin and C. difficile Risk: When to Seek Care
Clindamycin can trigger a dangerous gut infection called C. difficile. Learn the warning signs, when to seek care, and how to protect yourself from this serious antibiotic side effect.
Read More
Quercetin and Medications: How Supplement Use Can Raise Drug Levels and Cause Dangerous Interactions
Quercetin and Medications: How Supplement Use Can Raise Drug Levels and Cause Dangerous Interactions
Quercetin supplements can dangerously raise levels of common medications by blocking liver enzymes. Learn which drugs are affected, who's at risk, and how to avoid life-threatening interactions.
Read More
Evergreening: How Pharmaceutical Brands Delay Generic Drugs to Protect Profits
Evergreening: How Pharmaceutical Brands Delay Generic Drugs to Protect Profits
Evergreening lets pharmaceutical companies extend drug patents with minor tweaks, blocking cheaper generics and keeping prices high. Learn how this legal strategy impacts drug access and what’s being done to stop it.
Read More
CYP450 Interactions: Grapefruit, Warfarin, and SSRIs Explained
CYP450 Interactions: Grapefruit, Warfarin, and SSRIs Explained
Grapefruit can dangerously interfere with warfarin and certain SSRIs by blocking CYP450 enzymes that break down medications. Learn which drugs are at risk, why timing doesn't help, and what to do to stay safe.
Read More
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
The FDA's Purple Book is the official guide to biosimilars and interchangeable biological products in the U.S. Learn how it works, why interchangeability matters, and how to find approved products for safer, lower-cost treatment options.
Read More
Stability Testing: Long-Term Quality Monitoring Post-Manufacture in Pharmaceuticals
Stability Testing: Long-Term Quality Monitoring Post-Manufacture in Pharmaceuticals
Stability testing ensures pharmaceuticals remain safe and effective after manufacturing. Learn how ICH guidelines, real-time monitoring, and advanced analytics protect drug quality over time.
Read More
What Is a Drug Formulary? A Simple Guide for Patients on Costs, Tiers, and Coverage
What Is a Drug Formulary? A Simple Guide for Patients on Costs, Tiers, and Coverage
A drug formulary is your insurance plan's list of covered medications, organized into tiers that affect your out-of-pocket costs. Learn how tiers work, how to check your formulary, and what to do if your drug isn't covered.
Read More